TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Panadact Life Science AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
121
|
100
|
111 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
46
|
60
|
16 |
| EBITDA |
28
|
-6
|
16 |
| Total assets |
185
|
165
|
99 |
| Current assets |
131
|
118
|
53 |
| Current liabilities |
94
|
62
|
27 |
| Equity capital |
58
|
81
|
61 |
| - share capital |
4
|
5
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
31.4%
|
49.1%
|
61.6% |
| Turnover per employee |
121
|
100
|
111 |
| Profit as a percentage of turnover |
38.0%
|
60.0%
|
14.4% |
| Return on assets (ROA) |
24.9%
|
36.4%
|
16.2% |
| Current ratio |
139.4%
|
190.3%
|
196.3% |
| Return on equity (ROE) |
79.3%
|
74.1%
|
26.2% |
| Change turnover |
29
|
-9
|
11 |
| Change turnover % |
31%
|
-8%
|
11% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.